Save Article

“For investors we must demonstrate that we are EBITDA positive,” says Liberty Health Sciences Inc. (CSE:LHS) CEO George Scorsis



Liberty Health Sciences Inc. (CSE:LHS) is a vertically-integrated operator of U.S. focused cannabis businesses. The Company is looking to occupy the leadership position in Florida’s medical cannabis market and has plans to move into Massachusetts next. Speaking to SmallCapPower at the recent Benzinga Cannabis Capital Conference, CEO George Scorsis says, “with $30 million in deployable cash on our books we are fully capitalized to complete all projects.” The CEO also states that the cannabis euphoria among investors does not compare to the Dotcom bubble of the nineties because of the tangible assets that the cannabis industry owns.

To read our full disclosure, please click on the button below:

DISCLOSURE

The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.